CCL2 is considered an endogenous initiator of neuropathic pain (17–20) by directly sensitizing nociceptors (15), exciting DRG neurons (15–17), and enhancing glutamate release of primary afferents and postsynaptic glutamate receptor function in the superficial dorsal horn (18, 42). The gene discussed is CCL2; the disease is neuropathic pain.